Authors:
WOLKIN A
RUSINEK H
VAID G
ARENA L
LAFARGUE T
SANFILIPO M
LONERAGAN C
LAUTIN A
ROTROSEN J
Citation: A. Wolkin et al., STRUCTURAL MAGNETIC-RESONANCE IMAGE AVERAGING IN SCHIZOPHRENIA, The American journal of psychiatry, 155(8), 1998, pp. 1064-1073
Authors:
WOLKIN A
SANFILIPO M
DUNCAN E
ANGRIST B
WOLF AP
COOPER TB
BRODIE JD
LASKA E
ROTROSEN JP
Citation: A. Wolkin et al., BLUNTED CHANGE IN CEREBRAL GLUCOSE-UTILIZATION AFTER HALOPERIDOL TREATMENT IN SCHIZOPHRENIC-PATIENTS WITH PROMINENT NEGATIVE SYMPTOMS, The American journal of psychiatry, 153(3), 1996, pp. 346-354
Authors:
WOLKIN A
DUNCAN E
SANFILIPO M
WIELAND S
COOPER TB
ROTROSEN J
Citation: A. Wolkin et al., PERSISTENT PSYCHOSIS AFTER REDUCTION IN PRESYNAPTIC AND POSTSYNAPTIC DOPAMINERGIC FUNCTION, Journal of neural transmission, 95(1), 1994, pp. 49-61
Authors:
WOLKIN A
SANFILIPO M
ANGRIST B
DUNCAN E
WIELAND S
WOLF AP
BRODIE JD
COOPER TB
LASKA E
ROTROSEN JP
Citation: A. Wolkin et al., ACUTE D-AMPHETAMINE CHALLENGE IN SCHIZOPHRENIA - EFFECTS ON CEREBRAL GLUCOSE-UTILIZATION AND CLINICAL SYMPTOMATOLOGY, Biological psychiatry, 36(5), 1994, pp. 317-325
Authors:
DUNCAN E
SANFILIPO M
WIELAND S
ANGRIST B
ROTROSEN J
Citation: E. Duncan et al., NEUROLOGICAL SOFT SIGNS IN SCHIZOPHRENIA - RELATIONSHIP TO THOUGHT-DISORDER, Biological psychiatry, 35(9), 1994, pp. 715-715
Citation: R. Wolfsohn et al., A PLACEBO-CONTROLLED TRIAL OF L-DOPA CARBIDOPA IN EARLY COCAINE ABSTINENCE, Neuropsychopharmacology, 9(1), 1993, pp. 49-53
Authors:
NOPONEN M
SANFILIPO M
SAMANICH K
RYER H
KO G
ANGRIST B
WOLKIN A
DUNCAN E
ROTROSEN J
Citation: M. Noponen et al., ELEVATED PLA(2) ACTIVITY IN SCHIZOPHRENICS AND OTHER PSYCHIATRIC-PATIENTS, Biological psychiatry, 34(9), 1993, pp. 641-649
Authors:
DUNCAN E
WOLKIN A
ANGRIST B
SANFILIPO M
WIELAND S
COOPER TB
ROTROSEN J
Citation: E. Duncan et al., PLASMA HOMOVANILLIC-ACID IN NEUROLEPTIC RESPONSIVE AND NONRESPONSIVE SCHIZOPHRENICS, Biological psychiatry, 34(8), 1993, pp. 523-528